ID

33319

Beschreibung

Study ID: 104065 Clinical Study ID: 104065 Study Title: Immune memory of GSK's DTPw-HBV/Hib vaccine by giving Plain PRP polysaccharide at 10 mths. Immuno & reacto of a booster dose of DTPw-HBV/Hib or DTPw-HBV or DTPw-HBV+Hib at 15-18 mths in infants previously primed with DTPw-HBV/Hib Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00169442  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completet Generic Name: Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine (KFT) Trade Name: Zilbrix/Hib Study Indication: Diphtheria; Haemophilus influenzae type b; Hepatitis B; Tetanus; Whole Cell Pertussis

Stichworte

Versionen (2)
  1. 05.12.18 05.12.18 -
  2. 05.12.18 05.12.18 -
Rechteinhaber

GSK group of companies

Hochgeladen am

5. Dezember 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Immune memory of Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine at infants (15 to 18 mths) - 104065

Englisch

Visit 1: Exclusion Criteria

1 Formulare  
Administrative data
Beschreibung

Administrative data

Date of Visit
Beschreibung

Date of Visit

Datentyp

date

Subject Number
Beschreibung

Subject Number

Datentyp

integer

Eligibility check
Beschreibung

Eligibility check

Did the subject meet all the entry criteria?
Beschreibung

Did the subject meet all the entry criteria?

Datentyp

boolean

If No, please tick all boxes corresponding to violations of any inclusion/exclusion criteria
Beschreibung

Do not enter the subject into the study if he/she failed any inclusion or exclusion criteria listed below

Datentyp

text

Exclusion Criteria
Beschreibung

Exclusion Criteria

For subjects receiving Plain PRP followed by DTPw-HBV Kft:
Beschreibung

tick "Yes" for any of the exclusion criteria that disqualified the subject from entry

Datentyp

text

Use of investigational or non-registered product other than study vaccine within 30 days preceding administration of the study vaccine, or planned use during the study period.
Beschreibung

Use of investigational or non-registered product other than study vaccine within 30 days preceding administration of the study vaccine, or planned use during the study period.

Datentyp

boolean

Chronic administration (more than 14 days) of immunosuppressants or other immune-modifying drugs within six months prior to administration of the study vaccine.
Beschreibung

For corticosteroids, this will mean prednisone, or equivalent >=0.5 mg/kg/day. Inhaled and topical steroids are allowed

Datentyp

boolean

Planned administration/administration of vaccine not foreseen by the study protocol during the 30-day period starting before and ending 30 days after administration of the study vaccine with the exception of oral polio vaccine.
Beschreibung

Planned administration/administration of vaccine not foreseen by the study protocol during the 30-day period starting before and ending 30 days after administration of the study vaccine with the exception of oral polio vaccine.

Datentyp

boolean

Previous booster vaccination against diphteria, tetanus, pertussis, hepatitis B and/or Hib disease since the conclusion of the study DTPw=Hib Kft-001.
Beschreibung

Previous booster vaccination against diphteria, tetanus, pertussis, hepatitis B and/or Hib disease since the conclusion of the study DTPw=Hib Kft-001.

Datentyp

boolean

History of dyphtheria, tetanus, petrussis, hepatits B and/or Kft-001
Beschreibung

History of dyphtheria, tetanus, petrussis, hepatits B and/or Kft-001

Datentyp

boolean

Known exposure to diphtheria,tetanus, pertussis, hepatitis B and/or Hib disease
Beschreibung

Known exposure to diphtheria,tetanus, pertussis, hepatitis B and/or Hib disease

Datentyp

boolean

Any confirmed or suspected immunosuppressive or immunodeficient condition based on medical history and physical examination (no laboratory testing is required).
Beschreibung

Any confirmed or suspected immunosuppressive or immunodeficient condition based on medical history and physical examination (no laboratory testing is required).

Datentyp

boolean

A family history of congenital or hereditary immunodeficiency.
Beschreibung

A family history of congenital or hereditary immunodeficiency.

Datentyp

boolean

History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
Beschreibung

History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.

Datentyp

boolean

Major congenital defects or serious chronic illness.
Beschreibung

Major congenital defects or serious chronic illness.

Datentyp

boolean

History of any neurologic disorders or seizures.
Beschreibung

Subject who only had a single, uncomplicated febrile convulsion in the past can be included

Datentyp

boolean

Acute disease at the time of enrollment.
Beschreibung

Acute disease - the presence of a moderate or severe illness with or without fever; All vaccines can be administered to persons with a minor illness such as diarrhoea, mild upper respiratory infection with or without low-grade febrile illness, i.e. axillary t° <37.5°C/rectal t° <38°C

Datentyp

boolean

Administration of immunoglobulins and/or any blood products within the three months preceding administration of the study vaccine or planned administration during the study period.
Beschreibung

Administration of immunoglobulins and/or any blood products within the three months preceding administration of the study vaccine or planned administration during the study period.

Datentyp

boolean

Other conditions which in the opinion of the investigator may potentially interfere with interpretation of study outcomes.
Beschreibung

Other conditions which in the opinion of the investigator may potentially interfere with interpretation of study outcomes.

Datentyp

boolean

Specify other conditions.
Beschreibung

if necessary

Datentyp

text

Adverse events
Beschreibung

one of the following AE that constitute contraindications or precaution to further administration of DTP vaccine, having occurred after previous administration of DTP vaccine

Datentyp

text

Zum Seitenanfang zurückkehren

Ähnliche Modelle

Visit 1: Exclusion Criteria

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Administrative data
Date of Visit
Item
Date of Visit
date
Subject Number
Item
Subject Number
integer
Item Group
Eligibility check
Did the subject meet all the entry criteria?
Item
Did the subject meet all the entry criteria?
boolean
If No, please tick all boxes corresponding to violations of any inclusion/exclusion criteria
Item
If No, please tick all boxes corresponding to violations of any inclusion/exclusion criteria
text
Item Group
Exclusion Criteria
For subjects receiving Plain PRP followed by DTPw-HBV Kft:
Item
For subjects receiving Plain PRP followed by DTPw-HBV Kft:
text
Use of investigational or non-registered product other than study vaccine within 30 days preceding administration of the study vaccine, or planned use during the study period.
Item
Use of investigational or non-registered product other than study vaccine within 30 days preceding administration of the study vaccine, or planned use during the study period.
boolean
Chronic administration (more than 14 days) of immunosuppressants or other immune-modifying drugs within six months prior to administration of the study vaccine.
Item
Chronic administration (more than 14 days) of immunosuppressants or other immune-modifying drugs within six months prior to administration of the study vaccine.
boolean
Planned administration/administration of vaccine not foreseen by the study protocol during the 30-day period starting before and ending 30 days after administration of the study vaccine with the exception of oral polio vaccine.
Item
Planned administration/administration of vaccine not foreseen by the study protocol during the 30-day period starting before and ending 30 days after administration of the study vaccine with the exception of oral polio vaccine.
boolean
Previous booster vaccination against diphteria, tetanus, pertussis, hepatitis B and/or Hib disease since the conclusion of the study DTPw=Hib Kft-001.
Item
Previous booster vaccination against diphteria, tetanus, pertussis, hepatitis B and/or Hib disease since the conclusion of the study DTPw=Hib Kft-001.
boolean
History of dyphtheria, tetanus, petrussis, hepatits B and/or Kft-001
Item
History of dyphtheria, tetanus, petrussis, hepatits B and/or Kft-001
boolean
Known exposure to diphtheria,tetanus, pertussis, hepatitis B and/or Hib disease
Item
Known exposure to diphtheria,tetanus, pertussis, hepatitis B and/or Hib disease
boolean
Any confirmed or suspected immunosuppressive or immunodeficient condition based on medical history and physical examination (no laboratory testing is required).
Item
Any confirmed or suspected immunosuppressive or immunodeficient condition based on medical history and physical examination (no laboratory testing is required).
boolean
A family history of congenital or hereditary immunodeficiency.
Item
A family history of congenital or hereditary immunodeficiency.
boolean
History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
Item
History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
boolean
Major congenital defects or serious chronic illness.
Item
Major congenital defects or serious chronic illness.
boolean
History of any neurologic disorders or seizures.
Item
History of any neurologic disorders or seizures.
boolean
Acute disease at the time of enrollment.
Item
Acute disease at the time of enrollment.
boolean
Administration of immunoglobulins and/or any blood products within the three months preceding administration of the study vaccine or planned administration during the study period.
Item
Administration of immunoglobulins and/or any blood products within the three months preceding administration of the study vaccine or planned administration during the study period.
boolean
Other conditions which in the opinion of the investigator may potentially interfere with interpretation of study outcomes.
Item
Other conditions which in the opinion of the investigator may potentially interfere with interpretation of study outcomes.
boolean
Specify other conditions.
Item
Specify other conditions.
text
Item
Adverse events
text
Adverse events
Code List
Adverse events
CL Item
Hypersensitivity to any component of the vaccine, or signs of hypersensitivity after previous administration of diphtheria, tetanus, pertussis, hepatitis B and Hib vaccines (1)
CL Item
Encephalopathy (not due to another identifiable cause): acute, severe central nervous system disorder occurring within 7 days following vaccination->major alterations in consciousness, unresponsiveness, generalised or focal seizures that persist more than a few hours, with failure to recover within 24 hours (2)
CL Item
Axillary temperature of ≥ 40°C/rectal temperature ≥ 40.5°C within 48 hrs of vaccination (3)
CL Item
Collapse or shock-like state (hypotonic-hyporesponsive episode) within 48 hrs of vaccination (4)
CL Item
Persistent, inconsolable crying lasting ≥3 hrs, occurring within 48 hrs of vaccination (5)
CL Item
Convulsions with or without fever, occuring within 3 days of vaccination (6)
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video